Skip to main content
logo
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)
Egypt flag Egypt · Delayed Price · Currency is EGP
6.15
+0.08 (1.32%)
At close: Aug 25, 2026

EGX:RMDA Financials Overview

Millions EGP. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,3884,0962,7691,9221,4841,246
Revenue Growth
22.69%47.94%44.03%29.54%19.06%29.81%
Gross Profit
2,1851,9821,284904.06718.67576.82
Operating Income
1,006962.45725.44445.76342.26274.29
Net Income
301.01268.61363.84223.5228.91166.39
Earnings Per Share
0.150.130.180.110.120.08
EPS Growth
-27.50%-26.23%60.98%-3.52%41.22%70.69%

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Sales of Pharmaceutical Products
4,0953,8112,5871,7881,3521,169
Services Toll Manufacturing
293.35284.79181.87134.01132.4477.49
Total
4,3884,0962,7691,9221,4841,246

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
104.8536.18254.39313.25428.82482.01
Total Debt
2,4142,4091,5661,114930.18879.94
Net Cash (Debt)
-2,309-2,372-1,312-801.18-501.37-397.93
Net Cash Growth
------
Net Cash Per Share
-1.14-1.18-0.65-0.40-0.26-0.20

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
295.76-43.67-306.92-44.529.35241.35
Capital Expenditures
-144.46-155.9-64.93-91.05-34.38-52.67
Free Cash Flow
151.3-199.57-371.85-135.54-5.03188.68
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
49.80%48.39%46.38%47.03%48.43%46.28%
Operating Margin
22.93%23.50%26.20%23.19%23.06%22.01%
Pretax Margin
10.45%10.35%19.00%17.03%22.13%18.74%
Profit Margin
6.86%6.56%13.14%11.63%15.43%13.35%
FCF Margin
3.45%-4.87%-13.43%-7.05%-0.34%15.14%

Dividends
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
Dividend Per Share
0.040-0.0400.051
Dividend Per Share Growth
-62.69%--20.71%-
Dividend Yield
0.66%-1.64%4.32%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
41.2724.7913.8011.0012.6314.42
Forward PE
18.399.1910.847.729.2510.10
P/FCF Ratio
82.63----12.72
PS Ratio
2.851.631.811.281.951.93